Gene therapy of hemophilia: Hub centres should be haemophilia centres: A joint publication of EAHAD and EHC

Authors:

Publisher website

9 March 2022

journal article
letter
Published by Wiley in Haemophilia

Vol. 28 (3) , E86-E88
DOI:10.1111/hae.14546
PMID:35263819

Abstract

No abstract available

This publication has 6 references indexed in Scilit:

Delivery of AAV‐based gene therapy through haemophilia centres—A need for re‐evaluation of infrastructure and comprehensive care: A Joint publication of EAHAD and EHC
Haemophilia, 2021
Gene therapy for hemophilia: a review on clinical benefit, limitations, and remaining issues
Blood, 2021
Viral hepatitis in haemophilia: historical perspective and current management
British Journal of Haematology, 2021
Current Clinical Applications of In Vivo Gene Therapy with AAVs
Molecular Therapy, 2021
Kreuth V initiative: European consensus proposals for treatment of hemophilia using standard products, extended half-life coagulation factor concentrates and non-replacement therapies
Haematologica, 2020
How to discuss gene therapy for haemophilia? A patient and physician perspective
Haemophilia, 2019